Cargando…

Policy Implications for Diabetes Prevention and Control: An Experience from Iran

Background: Diabetes and its complications threaten the life of communities at global, national, and sub-national levels. Following the United Nations' call to action and develop a global action plan for the prevention and control of NCDs by The World Health Organization (WHO), all countries ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peykari, Niloofar, Ghaemi, Fatemeh, Nasli, Ensieh, Mahdavi Hazaveh, Ali Reza, Yousefi, Elham, Monji, Hadi, Shadnoush, Mahdi, Farzadfar, Farshad, Larijani, Bagher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Iran University of Medical Sciences 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9997414/ https://www.ncbi.nlm.nih.gov/pubmed/36908939 http://dx.doi.org/10.47176/mjiri.36.178

Ejemplares similares

Inequality of obesity and socioeconomic factors in Iran: a systematic review and meta- analyses
por: Djalalinia, Shirin, et al.
Publicado: (2015)

A Systematic Review on the Prevalence of Overweight and Obesity, in Iranian Children and Adolescents
por: Djalalinia, Shirin, et al.
Publicado: (2016)

Socioeconomic inequalities and diabetes: A systematic review from Iran
por: Peykari, Niloofar, et al.
Publicado: (2015)

Iran Diabetes Research Roadmap (IDRR): the study protocol
por: Shafiee, Gita, et al.
Publicado: (2016)

Inequalities in the prevalence, diagnosis awareness, treatment coverage and effective control of diabetes: a small area estimation analysis in Iran
por: Perseh, Lida, et al.
Publicado: (2023)

Obesity Researches Over the Past 24 years: A Scientometrics Study in Middle East Countries
por: Djalalinia, Shirin, et al.
Publicado: (2015)

Diabetes research in Middle East countries; a scientometrics study from 1990 to 2012
por: Peykari, Niloofar, et al.
Publicado: (2015)

National and sub-national burden and trend of type 1 diabetes in 31 provinces of Iran, 1990–2019
por: Bandarian, Fatemeh, et al.
Publicado: (2023)

Mortality Attributable to Excess Body Mass Index in Iran: Implementation of the Comparative Risk Assessment Methodology
por: Djalalinia, Shirin, et al.
Publicado: (2015)

Some Facts on the Diabetes Surveillance in Rural Regions of Iran
por: MAHDAVI HAZAVEH, Ali Reza, et al.
Publicado: (2018)

Iran diabetes research roadmap (IDRR) study: a preliminary study on diabetes research in the world and Iran
por: Nasli-Esfahani, Ensieh, et al.
Publicado: (2017)

Developing a Clinical Diabetes Guideline in Diabetes Research Network in Iran
por: NASLI-ESFAHANI, Ensieh, et al.
Publicado: (2014)

Social determinants of health inequity in Iran: a narrative review
por: Rezaei, Negar, et al.
Publicado: (2022)

Trend and projection of mortality rate due to non-communicable diseases in Iran: A modeling study
por: Khosravi Shadmani, Fatemeh, et al.
Publicado: (2019)

Scientometric Study on Non-communicable Diseases in Iran: A Review Article
por: PEYKARI, Niloofar, et al.
Publicado: (2018)

Iran to achieve the SDG 3.4 at national and sub-national levels
por: Haghdoost, Ali Akbar, et al.
Publicado: (2022)

Insulin pen use and diabetes treatment goals: A study from Iran STEPS 2016 survey
por: Ebrahimi, Hedyeh, et al.
Publicado: (2019)

Diabetes management during Ramadan amid Covid-19 pandemic
por: Tootee, Ali, et al.
Publicado: (2020)

Physical Activity Behavior During the COVID-19 Outbreak in Individuals with Type 2 Diabetes: Role of Social Support and Other Covariates
por: Peimani, Maryam, et al.
Publicado: (2022)

Evidence Gap and Knowledge Map of Physical Activity Research in Diabetes in Iran: A Scoping Review
por: Sanjari, Mahnaz, et al.
Publicado: (2021)

Non-communicable Diseases and COVID-19; a double-edged sword A Special Communication from IRAN
por: Peykari, Niloofar, et al.
Publicado: (2020)

National action plan for non-communicable diseases prevention and control in Iran; a response to emerging epidemic
por: Peykari, Niloofar, et al.
Publicado: (2017)

High Fasting Plasma Glucose Mortality Effect: A Comparative Risk Assessment in 25–64 Years Old Iranian Population
por: Peykari, Niloofar, et al.
Publicado: (2016)

Changes in clinic visits and diabetes and metabolic control in patients with type 2 diabetes during COVID-19 pandemic: A real world evidence
por: Bandarian, Fatemeh, et al.
Publicado: (2023)

Trends of Diabetes Mortality in Iran at National and Sub-National Levels from 1990 to 2015 and Its Association with Socioeconomic Factors
por: Peykari, Niloofar, et al.
Publicado: (2022)

The Effect of the COVID-19 Pandemic on Non-Communicable Disease Prevention and Management Services in the Primary Health Care System of Iran
por: Afkar, Mehdi, et al.
Publicado: (2022)

Telehealth for fighting the novel coronavirus: review of activities on Diabetes and Osteoporosis management in outbreak
por: Sanjari, Mahnaz, et al.
Publicado: (2020)

Diabetes in Iran: Prospective Analysis from First Nationwide Diabetes Report of National Program for Prevention and Control of Diabetes (NPPCD-2016)
por: Esteghamati, Alireza, et al.
Publicado: (2017)

Targeted metabolomics analysis of amino acids and acylcarnitines as risk markers for diabetes by LC–MS/MS technique
por: Hosseinkhani, Shaghayegh, et al.
Publicado: (2022)

Metabolic signatures of insulin resistance in non-diabetic individuals
por: Arjmand, Babak, et al.
Publicado: (2022)

Inequality in prevalence, awareness, treatment, and control of hypertension in Iran: the analysis of national households’ data
por: Mahdavi, Mahdi, et al.
Publicado: (2022)

Mechanisms involved in altered bone metabolism in diabetes: a narrative review
por: Ghodsi, Maryam, et al.
Publicado: (2016)

Amino acid profiling in the gestational diabetes mellitus
por: Rahimi, Najmeh, et al.
Publicado: (2017)

Prevalence of Non-Engineered Buildings and Population at Risk for a Probable Earthquake: A Cross-Sectional Study from an Informal Settlement in Tehran, Iran
por: FATHOLLAHI, Soraya, et al.
Publicado: (2020)

Impact of rural family physician program on child mortality rates in Iran: a time-series study
por: Naderimagham, Shohreh, et al.
Publicado: (2017)

Design and synthesis of phenoxymethybenzoimidazole incorporating different aryl thiazole-triazole acetamide derivatives as α-glycosidase inhibitors
por: Nasli Esfahani, Anita, et al.
Publicado: (2021)

Association of Zinc, Copper and Magnesium with bone mineral density in Iranian postmenopausal women – a case control study
por: Razmandeh, Rezvan, et al.
Publicado: (2014)

COVID-19-specific worries among people with type 2 diabetes following the continuation of the pandemic and occurrence of multiple waves of COVID-19 in Iran
por: Peimani, Maryam, et al.
Publicado: (2022)

Psychometric properties of the Iranian version of Diabetes Empowerment Scale (IR-DES-28)
por: Mahjouri, Mohammad Yoosef, et al.
Publicado: (2012)

Non-communicable diseases’ risk factors in Iran; a review of the present status and action plans
por: Azadnajafabad, Sina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9und7vh25krp3c4cah7inmun05